We are looking for children aged 2 to 17 years to join a Crohn’s disease clinical research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or CD (including associated symptoms such as swollen joints, kidney stones, rectal pain, chronic fatigue and/or liver disease), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.
Your child may be eligible to take part in the trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
See if your child qualifies.
